Wouter van Elmpt

Citée par

	Toutes	Depuis 2016
Citations	7577	5774
indice h	47	38
indice i10	100	95

1700

850

425

1275

20072008200920102011201220132014201520162017201820192020202120 36 81 96 129 188 283 384 526 662 952 1103 1325 1646 63

Coauteurs

Philippe LambinProfessor of Precision Medicine, Maastricht UniversityAdresse e-mail validée de maastrichtuniversity.nl
Andre DekkerProfessor of Clinical Data Science, MAASTRO Clinic, Maastricht University, GROW, Maastricht UMC+Adresse e-mail validée de maastro.nl
Ralph T.H. LeijenaarPostdoc at Maastricht University, Maastricht, the NetherlandsAdresse e-mail validée de maastrichtuniversity.nl
Esther TroostResident in Radiation OncologyAdresse e-mail validée de uniklinikum-dresden.de
Catharina M.L. ZegersDepartment of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental BiologyAdresse e-mail validée de maastro.nl
Felix MottaghyDepartment of Nuclear Medicine, University Hospital RWTH Aachen UniversityAdresse e-mail validée de ukaachen.de
Hugo AertsDirector AIM @ Harvard-BWH; DFCI; MGHAdresse e-mail validée de dfci.harvard.edu
Ronald BoellaardProfessor Clinical Physics of Positron Emission Tomography, VUmc, AmsterdamAdresse e-mail validée de vumc.nl
Frank HoebersDepartment of Radiation Oncology (MAASTRO), Research Institute GROW, Maastricht UniversityAdresse e-mail validée de maastro.nl
Arthur JochemsMaastricht UniversityAdresse e-mail validée de maastrichtuniversity.nl
Sara João CarvalhoBioinformatician @ Cambridge UniversityAdresse e-mail validée de medschl.cam.ac.uk
Ludwig DuboisMaastricht UniversityAdresse e-mail validée de maastrichtuniversity.nl
Erik RoelofsMAASTRO Clinic, Maastricht University, GROWAdresse e-mail validée de maastro.nl
Emmanuel Rios VelazquezResearcher @ imec The NetherlandsAdresse e-mail validée de imec-nl.nl
Hoda SharifiPhD, Henry Ford Health SystemAdresse e-mail validée de hfhs.org
Ruud G.P.M. van StiphoutPost-doctoral researcher, University of OxfordAdresse e-mail validée de ludwig.ox.ac.uk
Jonas ErikssonUppsala University, Uppsala University HospitalAdresse e-mail validée de ilk.uu.se
Sarah GJA PeetersUniversity of OxfordAdresse e-mail validée de oncology.ox.ac.uk
Guillaume LandryDepartment of Radiation Oncology, University Hospital, LMU MunichAdresse e-mail validée de med.uni-muenchen.de
Wolfgang A. ToméProfessor, Albert Einstein College of MedicineAdresse e-mail validée de einsteinmed.org

Wouter van Elmpt

Maastricht University Medical Centre

Adresse e-mail validée de maastro.nl

radiotherapy functional imaging PET/CT lung cancer innovation


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Radiomics: the bridge between medical imaging and personalized medicine P Lambin, RTH Leijenaar, TM Deist, J Peerlings, EEC De Jong, ... Nature reviews Clinical oncology 14 (12), 749-762, 2017	944	2017
A literature review of electronic portal imaging for radiotherapy dosimetry W Van Elmpt, L McDermott, S Nijsten, M Wendling, P Lambin, B Mijnheer Radiotherapy and oncology 88 (3), 289-309, 2008	502	2008
Predicting outcomes in radiation oncology—multifactorial decision support systems P Lambin, RGPM Van Stiphout, MHW Starmans, E Rios-Velazquez, ... Nature reviews Clinical oncology 10 (1), 27-40, 2013	324	2013
Stability of FDG-PET Radiomics features: an integrated analysis of test-retest and inter-observer variability RTH Leijenaar, S Carvalho, ER Velazquez, WJC Van Elmpt, C Parmar, ... Acta oncologica 52 (7), 1391-1397, 2013	293	2013
The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis RTH Leijenaar, G Nalbantov, S Carvalho, WJ Van Elmpt, EGC Troost, ... Scientific reports 5, 11075, 2015	261	2015
The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer W van Elmpt, D De Ruysscher, A van der Salm, A Lakeman, ... Radiotherapy and Oncology 104 (1), 67-71, 2012	212	2012
Quantitative radiomics studies for tissue characterization: a review of technology and methodological procedures RTHM Larue, G Defraene, D De Ruysscher, P Lambin, W Van Elmpt The British journal of radiology 90 (1070), 20160665, 2017	207	2017
Rapid Learning health care in oncology’–an approach towards decision support systems enabling customised radiotherapy P Lambin, E Roelofs, B Reymen, ER Velazquez, J Buijsen, CML Zegers, ... Radiotherapy and Oncology 109 (1), 159-164, 2013	166	2013
A model of heart rate changes to detect seizures in severe epilepsy WJC Van Elmpt, TME Nijsen, PAM Griep, JBAM Arends Seizure 15 (6), 366-375, 2006	139	2006
A global calibration model for EPIDs used for transit dosimetry S Nijsten, WJC Van Elmpt, M Jacobs, BJ Mijnheer, A Dekker, P Lambin, ... Medical physics 34 (10), 3872-3884, 2007	136	2007
External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma RTH Leijenaar, S Carvalho, FJP Hoebers, HJWL Aerts, WJC Van Elmpt, ... Acta oncologica 54 (9), 1423-1429, 2015	132	2015
A comparative study of the hypoxia PET tracers [18F] HX4,[18F] FAZA, and [18F] FMISO in a preclinical tumor model SGJA Peeters, CML Zegers, NG Lieuwes, W van Elmpt, J Eriksson, ... International Journal of Radiation Oncology* Biology* Physics 91 (2), 351-359, 2015	131	2015
Clinical evaluation of atlas and deep learning based automatic contouring for lung cancer T Lustberg, J van Soest, M Gooding, D Peressutti, P Aljabar, ... Radiotherapy and Oncology 126 (2), 312-317, 2018	122	2018
Optimal gating compared to 3D and 4D PET reconstruction for characterization of lung tumours W van Elmpt, J Hamill, J Jones, D De Ruysscher, P Lambin, M Öllers European journal of nuclear medicine and molecular imaging 38 (5), 843-855, 2011	120	2011
Response assessment using 18F-FDG PET early in the course of radiotherapy correlates with survival in advanced-stage non–small cell lung cancer W van Elmpt, M Öllers, AMC Dingemans, P Lambin, D De Ruysscher Journal of Nuclear Medicine 53 (10), 1514-1520, 2012	115	2012
The next step in patient-specific QA: 3D dose verification of conformal and intensity-modulated RT based on EPID dosimetry and Monte Carlo dose calculations W van Elmpt, S Nijsten, B Mijnheer, A Dekker, P Lambin Radiotherapy and oncology 86 (1), 86-92, 2008	115	2008
Dual energy CT in radiotherapy: current applications and future outlook W van Elmpt, G Landry, M Das, F Verhaegen Radiotherapy and Oncology 119 (1), 137-144, 2016	113	2016
Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation HJWL Aerts, J Bussink, WJG Oyen, W van Elmpt, AM Folgering, D Emans, ... Lung cancer 75 (1), 73-76, 2012	103	2012
Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review A Van Baardwijk, WA Tomé, W Van Elmpt, SM Bentzen, B Reymen, ... Radiotherapy and Oncology 105 (2), 145-149, 2012	97	2012
Influence of gray level discretization on radiomic feature stability for different CT scanners, tube currents and slice thicknesses: a comprehensive phantom study RTHM Larue, JE van Timmeren, EEC de Jong, G Feliciani, RTH Leijenaar, ... Acta oncologica 56 (11), 1544-1553, 2017	94	2017

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Importer un PDF

Suivre les mises à jour de cet auteur

Citée par

Coauteurs